← Open Payments lookup

RONNIE BLOUNT: Open Payments

NPI 1720159098 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$945 in 51 payments from 14 companies in 2025. Trend: 2023 $340 · 2024 $84,870 · 2025 $945

Food & beverage: $945
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$168
Takeda Pharmaceuticals U.S.A., Inc.10$161
ABBVIE INC.9$137
Lundbeck LLC5$104
Otsuka America Pharmaceutical, Inc.4$100
Neurocrine BioSciences, Inc.2$49
IDORSIA PHARMACEUTICALS US INC2$42
Janssen Pharmaceuticals, Inc2$41
E.R. Squibb & Sons, L.L.C.2$38
Vanda Pharmaceuticals Inc.2$29

Products named: REXULTI, CAPLYTA, TRINTELLIX, VRAYLAR, INGREZZA, Quviviq, COBENFY, FANAPT.

Industry payments across GA — which companies pay providers there.